ArticleEClinicalMedicine2020

Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study.

Nicolas Folschweiller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.